top of page

Nucleic Acid Immunity
in Health and Disease

September 22-26, 2019

Congressi Stefano Franscini

Monte Verità, Switzerland

At the 2019 conference held at the picturesque Congress Center in Monte Verità, researchers enthusiastically delved into the molecular mechanisms and functional consequences of the innate immune recognition of nucleic acids. The vibrant discussions highlighted breakthroughs in understanding how the immune system detects infectious microbes and the role of erroneous self-nucleic acid sensing in sterile inflammatory diseases. These exciting insights drive the development of groundbreaking treatments for infections, inflammatory diseases, and cancer.

NAIM19 Group Picture in Monte Verita, Switzerland

NAIM19 Participants at the Ponte dei Salti crossing the Verzasca in Lavertezzo, Switzerland

Foto: S. Marchegiano | EPFL

Program Features

Relive the highlights from our extraordinary 2019 conference, the inaugural Nucleic Acid Immunity Meeting! This dynamic program showcased groundbreaking research and insightful abstracts, fostering collaboration among researchers in the field. This exceptional event not only paved the way for future conferences but also led to the establishment of the International Society of Nucleic Acid Immunity in 2023. Stay tuned for more exciting opportunities to engage with cutting-edge research and experts in Nucleic Acid Immunity!

3 days

20 Invited Speakers

Excursion to

Valle Verasca

For more detailed information please scroll down on this page.

Our Speakers

We express our sincere appreciation to the three keynote speakers, the 20 invited speakers of the Nucleic Acid Immunity Meeting 2019 - NAIM19. Your invaluable insights and expertise have been instrumental in shaping this conference, rendering it truly outstanding.

Invited Speakers
  • Andrea Ablasser, Ecole Polytechnique Fédérale de Lausanne

  • Glen Barber, University of Miami Leonard M. Miller School of Medicine

  • Julie Magarian Blander, Cornell University

  • Carole Bourquin, University of Geneva

  • Zhijian ‘James’ Chen, University of Texas Southwestern Medical Center

  • Yanick Crow, The University of Edinburgh

  • Michel Gilliet, University of Lausanne

  • Raphaela Goldbach-Mansky, National Institute of Allergy and Infectious Diseases, Bethesda

  • Gunther Hartmann, University of Bonn

  • Sun Hur, Harvard Medical School

  • Karl-Peter Hopfner, Ludwig-Maximilians-Universität München

  • Andrew Jackson, The University of Edinburgh

  • Hiroki Kato, University of Bonn

  • Philip Kranzusch, Dana-Farber Cancer Institute, Boston

  • Min Ae Lee-Kirsch, Universitätsklinikum Carl Gustav Carus, Dresden

  • Nicolas Manel, Institut Curie, Paris

  • Fabio Martinon, University of Lausanne

  • Andreas Pichlmair, Technical University of Munich

  • Jan Rehwinkel, University of Oxford

  • Axel Roers, Technische Universität Dresden

Our Team of Organizers

The success of NAIM19 was made possible by the stellar organization of local luminaries Andrea Ablasser and Fabio Martinon, alongside Gunther Hartmann, speaker of the newly established TRR237. Their collaborative vision and dedication resulted in an exceptional conference experience, catalyzing innovation and collaboration within the field of Nucleic Acid Immunity.


  • Sonia Marchegiano, Ablasser Lab, EPFL, Switzerland


NAIS19 Sponsor UCB Pharma
NAIS19 Supporter ETH Zurich
NAIS19 Supporter ETH Congressi Stefano Franscini
bottom of page